« Return to News | Awards & Advancement

Fuchs joins Provectus advisory board

Friday, July 15, 2011 10:48 AM

Provectus Pharmaceuticals, a development-stage oncology and dermatology biopharmaceutical company, has named Stuart Fuchs to its corporate advisory board. He is resigning from the board of directors.

Fuchs was previously a co-founder and managing principal of Gryffindor Capital Partners and before that was with Goldman Sachs for 19 years. Before becoming an investment banker, he practiced law. He also serves as chairman and CEO of CognoSPECTi, a start-up venture.

Dr. Craig Dees, PhD., CEO of Provectus said, “Stuart has provided many years of service to Provectus Pharmaceuticals as a member of our board of directors. As we transition our board of directors to becoming an independent board, Stuart, who has been a consultant to Provectus Pharmaceuticals, has agreed to transition off our board of directors, and join our corporate advisory board, where he will still remain active as an advisor to our company.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.